Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceuticals ranked by total assets, at AED 560.5M, followed by Erasca (AED 1.5B) and Definium Therapeutics (AED 1.6B). Figures as of 18 Nov 2026, 16:35 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsAED 560.5M
- Median
- AED 12.9B
- Combined market value
- AED 18.7T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | AED 560.5M | AED 19.4B | AED 459.45 | 0.43% down | 233% up | ||
| 2 | ErascaERAS · Health Care | AED 1.5B | AED 17B | AED 48.55 | 4.82% down | 403% up | ||
| 3 | Definium TherapeuticsDFTX · Health Care | AED 1.6B | AED 14.4B | AED 105.20 | 2.50% down | 169% up | ||
| 4 | Rhythm PharmaceuticalsRYTM · Health Care | AED 1.8B | AED 29.8B | AED 429.63 | 0.32% up | 13% up | ||
| 5 | Oruka TherapeuticsORKA · Health Care | AED 1.8B | AED 24.1B | AED 355.30 | 0.44% up | 241% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | AED 1.9B | AED 17.8B | AED 316.73 | 0.85% down | 113% up | ||
| 7 | Edgewise TherapeuticsEWTX · Health Care | AED 2B | AED 16.6B | AED 151.21 | 2.07% down | 88% up | ||
| 8 | Travere TherapeuticsTVTX · Health Care | AED 2.2B | AED 17.8B | AED 184.96 | 1.45% down | 44% up | ||
| 9 | ABIVAXABVX · Health Care | AED 2.4B | AED 27B | AED 308.78 | 2.41% up | 27% down | ||
| 10 | Protagonist TherapeuticsPTGX · Health Care | AED 2.5B | AED 30B | AED 460.19 | 0.51% up | 46% up | ||
| 11 | Axsome TherapeuticsAXSM · Health Care | AED 2.5B | AED 25.7B | AED 488.07 | 2.25% down | 7% down | ||
| 12 | Summit TherapeuticsSMMT · Health Care | AED 2.8B | AED 31.3B | AED 39.11 | 0.20% down | 36% down | ||
| 13 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | AED 2.8B | AED 27.7B | AED 352.43 | 0.89% up | 126% up | ||
| 14 | Spyre TherapeuticsSYRE · Health Care | AED 2.9B | AED 33.3B | AED 350.71 | 1.79% up | 286% up | ||
| 15 | Belite BioBLTE · Health Care | AED 2.9B | AED 23.7B | AED 583.98 | 0.81% up | 31% up | ||
| 16 | Corcept TherapeuticsCORT · Health Care | AED 3.1B | AED 27.4B | AED 250.44 | 2.68% down | 8% down | ||
| 17 | Mirum PharmaceuticalsMIRM · Health Care | AED 3.1B | AED 21.9B | AED 335.68 | 0.60% down | 31% up | ||
| 18 | BridgeBio PharmaBBIO · Health Care | AED 3.4B | AED 55.6B | AED 285.59 | 1.25% up | 17% up | ||
| 19 | Cogent BiosciencesCOGT · Health Care | AED 3.4B | AED 18.1B | AED 104.14 | 1.81% up | 20% down | ||
| 20 | Praxis Precision MedicinesPRAX · Health Care | AED 3.4B | AED 31.3B | AED 1,121.11 | 0.06% up | 61% up | ||
| 21 | TG TherapeuticsTGTX · Health Care | AED 3.9B | AED 36.2B | AED 239.46 | 3.97% up | 107% up | ||
| 22 | Madrigal PharmaceuticalsMDGL · Health Care | AED 4.6B | AED 34.8B | AED 1,499.34 | 3.26% down | 24% down | ||
| 23 | Arrowhead PharmaceuticalsARWR · Health Care | AED 5.1B | AED 22.4B | AED 158.15 | 0.16% up | 10% up | ||
| 24 | CytokineticsCYTK · Health Care | AED 5.2B | AED 26.2B | AED 188.32 | 0.73% down | 20% down | ||
| 25 | Ascendis PharmaASND · Health Care | AED 5.3B | AED 65.2B | AED 993.36 | 0.27% down | 28% up | ||
| 26 | Ligand PharmaceuticalsLGND · Health Care | AED 5.7B | AED 22.1B | AED 1,105.85 | 2.48% up | 43% up | ||
| 27 | Legend BiotechLEGN · Health Care | AED 6.4B | AED 11.6B | AED 59.68 | 0.87% up | 42% down | ||
| 28 | InsmedINSM · Health Care | AED 8.3B | AED 96.8B | AED 441.31 | 1.40% down | 40% down | ||
| 29 | AlkermesALKS · Health Care | AED 9.1B | AED 28.8B | AED 171.48 | 2.73% up | 58% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | AED 10.6B | AED 18.5B | AED 221.21 | 0.22% down | 20% down | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | AED 12.9B | AED 16.7B | AED 100.28 | 1.28% up | 64% down | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | AED 13.5B | AED 27.6B | AED 79.11 | 1.99% up | 83% up | ||
| 33 | Alnylam PharmaceuticalsALNY · Health Care | AED 18.2B | AED 75B | AED 559.61 | 2.64% down | 66% down | ||
| 34 | Roivant SciencesROIV · Health Care | AED 21B | AED 102.5B | AED 141.51 | 0.46% down | 90% up | ||
| 35 | Dr. Reddy's LaboratoriesRDY · Health Care | AED 22.6B | AED 45.9B | AED 55.05 | 1.35% up | 5% up | ||
| 36 | BioMarin PharmaceuticalBMRN · Health Care | AED 27.9B | AED 42.9B | AED 221.24 | 2.96% up | 11% up | ||
| 37 | United TherapeuticsUTHR · Health Care | AED 28.9B | AED 90.7B | AED 2,130.64 | 0.68% down | 23% up | ||
| 38 | BeOne MedicinesONC · Health Care | AED 30.1B | AED 169.7B | AED 1,486.01 | 2.09% down | 17% up | ||
| 39 | Jazz PharmaceuticalsJAZZ · Health Care | AED 42.8B | AED 57.6B | AED 896.72 | 1.43% up | 37% up | ||
| 40 | GenmabGMAB · Health Care | AED 47.3B | AED 116.1B | AED 188.37 | 1.29% down | 70% up | ||
| 41 | Elanco Animal HealthELAN · Health Care | AED 49.1B | AED 48.6B | AED 97.25 | 2.44% up | 20% up | ||
| 42 | ZoetisZTS · Health Care | AED 56.8B | AED 125.4B | AED 308.71 | 0.69% up | 29% down | ||
| 43 | Royalty PharmaRPRX · Health Care | AED 72.1B | AED 145.3B | AED 252.72 | 0.19% up | 78% up | ||
| 44 | GrifolsGRFS · Health Care | AED 80.3B | AED 21.3B | AED 31.25 | 1.39% down | 1% up | ||
| 45 | Vertex PharmaceuticalsVRTX · Health Care | AED 94.2B | AED 498B | AED 1,964.07 | 0.11% up | 27% up | ||
| 46 | ViatrisVTRS · Health Care | AED 136.6B | AED 86.9B | AED 75.79 | 0.90% up | 96% up | ||
| 47 | Regeneron PharmaceuticalsREGN · Health Care | AED 149B | AED 364.5B | AED 3,523.26 | 0.16% up | 36% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | AED 149.7B | AED 180.4B | AED 154.62 | 1.22% down | 74% up | ||
| 49 | Novo NordiskNVO · Health Care | AED 295.9B | AED 641B | AED 145.44 | 2.70% down | 17% down | ||
| 50 | GSKGSK · Health Care | AED 297.9B | AED 359.6B | AED 179.37 | 0.81% down | 6% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | AED 318.5B | AED 665B | AED 383.94 | 0.16% down | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | AED 330.7B | AED 451.7B | AED 220.99 | 1.92% down | 34% up | ||
| 53 | Takeda PharmaceuticalTAK · Health Care | AED 356.8B | AED 250.9B | AED 78.52 | 1.20% down | 54% up | ||
| 54 | NovartisNVS · Health Care | AED 407.5B | AED 1.08T | AED 573.05 | 1.95% down | 25% up | ||
| 55 | Eli LillyLLY · Health Care | AED 413.1B | AED 4.55T | AED 5,110.05 | 1.71% down | 35% up | ||
| 56 | AstraZenecaAZN · Health Care | AED 419B | AED 1.02T | AED 658.18 | 1.68% down | 2% up | ||
| 57 | AbbVieABBV · Health Care | AED 492B | AED 1.88T | AED 1,060.97 | 1.35% down | 26% up | ||
| 58 | Merck & CoMRK · Health Care | AED 502.7B | AED 1.27T | AED 513.30 | 2.52% down | 51% up | ||
| 59 | SanofiSNY · Health Care | AED 516.7B | AED 417.7B | AED 173.94 | 0.36% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | AED 731.6B | AED 2.44T | AED 1,012.89 | 1.04% down | 38% up | ||
| 61 | PfizerPFE · Health Care | AED 764.5B | AED 590B | AED 103.50 | 1.01% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6727 AED).
Questions and answers
Which pharmaceuticals have the lowest total assets?
Veradermics (AED 560.5M), Erasca (AED 1.5B) and Definium Therapeutics (AED 1.6B) have the lowest total assets of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:35 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of AED 18.7T as of 18 Nov 2026, 16:35 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.